'CRIS against cancer' analyzes the importance of not stopping cancer treatments during the COVID wave

In this second wave of COVID-19, researchers from the CRIS foundation against cancer analyze the importance of not stopping cancer treatments, an issue that worries patients.

Dr. Pedro Segura, who leads the CRIS Unit for New Experimental Therapies of the Hospital Clínico San Carlos, together with Dr. Alberto Ocaña, explain the importance of not postponing cancer treatments and points out the immune response of patients with an affected defensive system, including cancer patients, when contracting Covid-19 and seeks to predict the evolution of the patient to anticipate solutions.

Dr. Segura points out that "Hospitals are articulating procedures so that these patients do not notice that there is an epidemic and go through a different circuit. The current approach is to treat them as if there were no pandemic, but with more exhaustive care, that they do not spend so much time in the hospital, the better oral medications rather than intravenous, having a very continuous follow-up through a telemedicine project that allows patients to be controlled without their coming, and the delivery of medications to their homes, etc. It is working very well. "

It also points out that awareness of the patient's environment is important, that knowing the importance of following isolation and protection measures, since part of the risk of the Covid infection itself for cancer patients is that they have to stop cancer treatment which is what really controls your disease.